The current study attempted to identify pleiotropic effects of variants in PCSK9, APOB, and LDLR that influence LDL-C levels with a particular focus on associations with diabetes, neurocognitive impairment, and cataracts given the concern raised in prior reports. The gene discussed is LDLR; the disease is cataract.